Cargando…

Profile of netarsudil ophthalmic solution and its potential in the treatment of open-angle glaucoma: evidence to date

Netarsudil ophthalmic solution is a novel topical intraocular pressure (IOP)-lowering agent that has recently been approved by the US Food and Drug Administration (FDA) for the treatment of ocular hypertension and open-angle glaucoma. Its unique pharmacology allows for IOP lowering as a result of di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dasso, Lily, Al-Khaled, Tala, Sonty, Sriram, Aref, Ahmad A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177382/ https://www.ncbi.nlm.nih.gov/pubmed/30323550 http://dx.doi.org/10.2147/OPTH.S154001

Ejemplares similares

Pooled Efficacy and Safety Profile of Netarsudil Ophthalmic Solution 0.02% in Patients With Open-angle Glaucoma or Ocular Hypertension
por: Singh, Inder P., et al.
Publicado: (2020)

Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
por: Araie, Makoto, et al.
Publicado: (2021)

Evaluating intraocular pressure-lowering solutions for the treatment of open-angle glaucoma: comparison between bimatoprost 0.03% and bimatoprost 0.01% — an observational switch study
por: Deshpande, Sarita S, et al.
Publicado: (2017)

Netarsudil-Induced Corneal Flattening in a Child with Secondary Open-Angle Glaucoma
por: Ganesh, Durga, et al.
Publicado: (2022)

A novel fixed-combination timolol-netarsudil-latanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension
por: Wang, Tao, et al.
Publicado: (2022)

The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans
por: Kazemi, Arash, et al.
Publicado: (2018)

A Randomized, Phase 2 Study of 24-h Efficacy and Tolerability of Netarsudil in Ocular Hypertension and Open-Angle Glaucoma
por: Peace, James H., et al.
Publicado: (2020)

Netarsudil monotherapy as the initial treatment for open-angle glaucoma and ocular hypertension in Indian patients: A real-world evaluation of efficacy and safety
por: Mathur, Manoj Chandra, et al.
Publicado: (2023)

Latanoprost ophthalmic solution in the treatment of open angle glaucoma or raised intraocular pressure: a review
por: Russo, Andrea, et al.
Publicado: (2008)

Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
por: Hoy, Sheridan M.
Publicado: (2018)

Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2
por: Asrani, Sanjay, et al.
Publicado: (2020)

Correction to: Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
por: Hoy, Sheridan M.
Publicado: (2018)

Latanoprostene bunod ophthalmic solution 0.024% in the treatment of open-angle glaucoma: design, development, and place in therapy
por: Addis, Victoria M, et al.
Publicado: (2018)

Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open‐angle glaucoma and ocular hypertension
por: Fingeret, Murray, et al.
Publicado: (2019)

Netarsudil-associated epithelial keratopathy
por: Ramakrishnan, Meera S., et al.
Publicado: (2020)

Efficacy and safety of netarsudil/latanoprost fixed-dose combination vs. monotherapy in open-angle glaucoma or ocular hypertension: A systematic review and meta-analysis of randomized controlled trials
por: Luo, Nachuan, et al.
Publicado: (2022)

Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
por: Lin, Cheng-Wen, et al.
Publicado: (2018)

Effectiveness of Netarsudil as an Additional Therapy for Glaucoma in Patients Already on Maximally Tolerated Medical Therapy
por: Villegas, Natacha C, et al.
Publicado: (2021)

Little evidence for association of the glaucoma gene MYOC with open-angle glaucoma
por: Sohn, Seongsoo, et al.
Publicado: (2010)

Comparison of ophthalmic artery blood flow between open-angle glaucoma and nonglaucomatous eyes of Indian patients
por: Mathur, Vijay, et al.
Publicado: (2020)

Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma
por: Wang, Yulong, et al.
Publicado: (2020)

Netarsudil-associated reticular corneal epithelial edema
por: Tran, Jennifer A., et al.
Publicado: (2022)

Reticular corneal epithelial edema with topical netarsudil
por: Parmar, Dipali P., et al.
Publicado: (2023)

Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)
por: Araie, Makoto, et al.
Publicado: (2023)

An Updated Review on the Genetics of Primary Open Angle Glaucoma
por: Abu-Amero, Khaled, et al.
Publicado: (2015)

Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension
por: Iester, Michele
Publicado: (2008)

Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects with Ocular Hypertension or Primary Open-Angle Glaucoma
por: Martin, Patrick, et al.
Publicado: (2020)

Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
por: Sun, Xinghuai, et al.
Publicado: (2022)

An evidence-based review of unoprostone isopropyl ophthalmic solution 0.15% for glaucoma: place in therapy
por: Fung, Derrick S, et al.
Publicado: (2014)

Acute bilateral angle closure glaucoma induced by methazolamide
por: Aref, Ahmad A, et al.
Publicado: (2013)

Lasers in primary open angle glaucoma
por: Sihota, Ramanjit
Publicado: (2011)

Medical treatment of open-angle glaucoma
por: Kyari, Fatima, et al.
Publicado: (2012)

Novel therapies for open-angle glaucoma
por: Wentz, Scott M., et al.
Publicado: (2014)

Micropulse Trabeculoplasty in Open Angle Glaucoma
por: Valera-Cornejo, Diego Alejandro, et al.
Publicado: (2018)

Neuroinflammation in Primary Open-Angle Glaucoma
por: Vernazza, Stefania, et al.
Publicado: (2020)

Management of chronic open-angle glaucoma
por: Philippin, Heiko
Publicado: (2021)

Preservative-Free versus Benzalkonium Chloride–Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial
por: Bacharach, Jason, et al.
Publicado: (2023)

Acute Angle-Closure Glaucoma Secondary to a Phakic Intraocular Lens, an Ophthalmic Emergency
por: Frost, Arian, et al.
Publicado: (2019)

Microvascular endothelial function and primary open angle glaucoma
por: Mudassar Imran Bukhari, Syed, et al.
Publicado: (2019)

Color visual acuity in preperimetric glaucoma and open-angle glaucoma
por: Ouchi, Junko, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lom8d5027j47pjfmm0q4n8baq3